• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC CARTO VIZIGO 8.5F BI-DIRECTIONAL GUIDING SHEATH - MEDIUM; INTRODUCER, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC CARTO VIZIGO 8.5F BI-DIRECTIONAL GUIDING SHEATH - MEDIUM; INTRODUCER, CATHETER Back to Search Results
Model Number D138502
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Cardiac Tamponade (2226)
Event Date 02/11/2021
Event Type  Death  
Manufacturer Narrative
The device has been reported as discarded, therefore no product investigation can be performed, and the customer complaint cannot be confirmed.Manufacturer record evaluation cannot be conducted because the no lot number was provided by the customer.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
 
Event Description
It was reported that a (b)(6) year-old female patient (b)(6) underwent premature ventricular contraction ablation (pvc) with a carto vizigo" 8.5f bi-directional guiding sheath - medium and suffered cardiac tamponade requiring pericardiocentesis, surgical intervention and death.After transseptal puncture the mitral valve (not the tricuspid valve) was passed to proceed with mapping and ablation using the smarttouch sf catheter.During the mapping, the specialist noticed a pericardial effusion in the intracardiac echo (ice) image.The physician stated the perforation could be at the moment of the transseptal puncture.An epicardial puncture was performed to drain the blood.Then it was determined necessary to open the chest to close the perforation, finding a perforation from the inferior vena cava to the right atrium.The physician also stated the 8mm perforation in the vena cava to the right atrium could be done in the surgery done to repair the perforation not in the ablation procedure.The patient passed away during the second procedure.Since the event is life-threatening and required intervention to prevent permanent impairment of a body function or permanent damage to a body structure, then it is to be considered serious and mdr-reportable.
 
Manufacturer Narrative
On 3/10/2021, bwi received additional event information which indicates the following: the physician¿s opinion on the cause of this adverse event: procedure.When the pericardial effusion was discovered on the intracardiac echo image the physician proceeded with the an epicardial puncture to drain the blood.Then, after approximately 1 hour it was necessary to perform a 2nd surgery with open chest close the perforation on the heart.The patient died.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARTO VIZIGO 8.5F BI-DIRECTIONAL GUIDING SHEATH - MEDIUM
Type of Device
INTRODUCER, CATHETER
Manufacturer (Section D)
BIOSENSE WEBSTER INC
33 technology drive
irvine CA 92618
MDR Report Key11431388
MDR Text Key238304204
Report Number2029046-2021-00266
Device Sequence Number1
Product Code DYB
UDI-Device Identifier10846835016277
UDI-Public10846835016277
Combination Product (y/n)N
PMA/PMN Number
K170997
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 02/11/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/08/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberD138502
Device Catalogue NumberD138502
Was Device Available for Evaluation? No
Date Manufacturer Received03/10/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
SMARTTOUCH SF CATHETER.; UNK_TRANSEPTAL NEEDLE.; SMARTTOUCH SF CATHETER; UNK_TRANSEPTAL NEEDLE
Patient Outcome(s) Death; Life Threatening; Required Intervention;
Patient Age70 YR
Patient Weight47
-
-